» Articles » PMID: 30449189

An Overview of Neural Networks for Drug Discovery and the Inputs Used

Overview
Specialties Chemistry
Pharmacology
Date 2018 Nov 20
PMID 30449189
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

: Artificial intelligence systems based on neural networks (NNs) find rules for drug discovery according to training molecules, but first, the molecules need to be represented in certain ways. Molecular descriptors and fingerprints have been used as inputs for artificial neural networks (ANNs) for a long time, while other ways for describing molecules are used only for storing and presenting molecules. With the development of deep learning, variants of ANNs are now able to use different kinds of inputs, which provide researchers with more choices for drug discovery. : The authors provide a brief overview of the applications of NNs in drug discovery. Combined with the characteristics of different ways for describing molecules, corresponding methods based on NNs provide new choices for drug discovery, including drug design, ligand-based drug design, and receptor-based drug design. : Various ways for describing molecules can be inputs of NN-based models, and these models achieve satisfactory results in metrics. Although most of the models have not been widely applied and tested in practice, they can be the basis for automatic drug discovery in the future.

Citing Articles

From Sequence to Solution: Intelligent Learning Engine Optimization in Drug Discovery and Protein Analysis.

Raiyn J, Rayan A, Abu-Lafi S, Rayan A BioTech (Basel). 2024; 13(3).

PMID: 39311335 PMC: 11417716. DOI: 10.3390/biotech13030033.


Revolutionizing Drug Discovery: The Role of Artificial Intelligence and Machine Learning.

Verma A, Awasthi A Curr Pharm Des. 2024; 30(11):807-810.

PMID: 38409722 DOI: 10.2174/0113816128298691240222054120.


OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds.

Yi J, Shi S, Fu L, Yang Z, Nie P, Lu A Nat Protoc. 2024; 19(4):1105-1121.

PMID: 38263521 DOI: 10.1038/s41596-023-00942-4.


Predicting the target landscape of kinase inhibitors using 3D convolutional neural networks.

Kanev G, Zhang Y, Kooistra A, Bender A, Leurs R, Bailey D PLoS Comput Biol. 2023; 19(9):e1011301.

PMID: 37669273 PMC: 10508635. DOI: 10.1371/journal.pcbi.1011301.


Forecasting COVID-19 Epidemic Trends by Combining a Neural Network with Estimation.

Cinaglia P, Cannataro M Entropy (Basel). 2022; 24(7).

PMID: 35885152 PMC: 9322732. DOI: 10.3390/e24070929.